Does Rallies show live market data for VCYT?

Rallies combines live market context with ticker research for VCYT, including charts, news, financials, analyst data, institutional holdings, politician trades, insider activity, and AI research where available.

VCYT (Veracyte, Inc.) Stock Analysis

Veracyte, Inc. (VCYT) is a publicly traded Healthcare sector company. As of May 21, 2026, VCYT trades at $45.19 with a market cap of $3.31B and a P/E ratio of 40.34. VCYT moved +8.37% today. Year to date, VCYT is +3.58%; over the trailing twelve months it is +56.86%. Its 52-week range spans $22.61 to $50.71. Analyst consensus is buy with an average price target of $45.28. Rallies surfaces VCYT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the latest VCYT stock research?

Veracyte, Inc. (VCYT) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. VCYT moved +8.37% today. Analyst consensus is buy.

VCYT Key Metrics

Key financial metrics for VCYT
Metric	Value
Price	$45.19
Market Cap	$3.31B
P/E Ratio	40.34
EPS	$1.11
Dividend Yield	0.00%
52-Week High	$50.71
52-Week Low	$22.61
Volume	0
Avg Volume	0
Revenue (TTM)	$541.74M
Net Income	$88.01M
Gross Margin	70.92%

Latest VCYT News

Veracyte Q1 EPS $0.52 on $139.1M Revenue Beats Forecast, Raises Guidance — May 5, 2026
Veracyte Q4 EPS Jumps 47%, Revenue Up 18.5%, Shares Rally — Feb 26, 2026
Veracyte Posts Over 20% Q4 Revenue Increase, Outlines Diagnostics Expansion — Feb 26, 2026
Veracyte Q4 EPS Beats by 30%, Revenues Rise 18.5% to $140.6M — Feb 26, 2026
Becton Dickinson Unveils Three-Tube Urine Cup Kit to Expand Diagnostics — Feb 24, 2026

Recent VCYT Insider Trades

McGuire Annie sold 5.10K (~$194.13K) on May 6, 2026.
McGuire Annie sold 5.10K (~$204.08K) on May 6, 2026.
Chambers Rebecca sold 4.40K (~$156.41K) on Mar 4, 2026.

VCYT Analyst Consensus

8 analysts cover VCYT: 0 strong buy, 6 buy, 1 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $45.28.

Common questions about VCYT

What can I research for VCYT on Rallies?: Veracyte, Inc. (VCYT) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. VCYT moved +8.37% today. Analyst consensus is buy.
Does Rallies show live market data for VCYT?: Rallies combines live market context with ticker research for VCYT, including charts, news, financials, analyst data, institutional holdings, politician trades, insider activity, and AI research where available.